Ischemic Stroke study: TDCS vs Cognitive Therapy
Official title Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
ClinicalTrials.gov ID: NCT04897334
What this study is testing
- What it's testing
- The study wants to find out if transcranial direct current stimulation combined with usual cognitive therapy can improve thinking abilities after a sub‑acute stroke.
- Who it's for
- Adults who have had an ischemic stroke and are experiencing cognitive impairment.
- What's involved
- Participants will receive transcranial direct current stimulation, a gentle electrical current to the scalp, together with regular cognitive therapy sessions.
This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 90
You may be able to join if
- Stroke that occurred within 4 weeks of the study
- Presence of cognitive impairment attributable to stroke
- Between the ages of 18 and 90
- Able to understand the nature of the study and give informed consent
- Able to follow simple commands as evidenced by NIHSS subtest 1C =0
You likely can't join if
- History of chronic, serious, or unstable neurologic illness other than stroke
- Current unstable medical illness(es)
- History of reoccurring seizures or epilepsy
- Current abuse of alcohol or drugs (prescription or otherwise)
- Active and severe psychiatric disorder
- Metallic objects in the face or head other than dental apparatus such as braces, fillings, and implants.
See the full eligibility criteria
- Stroke that occurred within 4 weeks of the study
- Presence of cognitive impairment attributable to stroke
- Between the ages of 18 and 90
- Able to understand the nature of the study and give informed consent
- Able to follow simple commands as evidenced by NIHSS subtest 1C =0
- History of chronic, serious, or unstable neurologic illness other than stroke
- Current unstable medical illness(es)
- History of reoccurring seizures or epilepsy
- Current abuse of alcohol or drugs (prescription or otherwise)
- Active and severe psychiatric disorder
- Metallic objects in the face or head other than dental apparatus such as braces, fillings, and implants.
- Pregnancy
The study team makes the final eligibility decision.
Where it is enrolling
- Philadelphia, Pennsylvania, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 90 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Philadelphia, Pennsylvania, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.